Results 221 to 230 of about 1,231,536 (373)

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

open access: yesMolecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen   +12 more
wiley   +1 more source

Supplementum 283: Abstracts of the Swiss Oncology & Hematology Congress (SOHC)

open access: yesSwiss Medical Weekly
Swiss Society of Medical Oncology   +2 more
doaj   +1 more source

Medical Oncology Analysis 1

open access: gold, 2002
David M. Gustin, Bharat Motwani
openalex   +1 more source

Home - About - Disclaimer - Privacy